Remedies for sjoegren's syndrome
CA 2399800 A1 · Owner: Ono Pharmaceutical Co. Ltd. · Inventors: Hayashi, Yoshio
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
It is found out that inducible NO synthase (i-NOS) is efficacious against Sjoegren's syndrome. Based on this finding remedies and/preventives for , Sjoegren's syndrome containing i-NOS inhibitors as the active ingredient are developed. As the i-NOS inhibitors, it is preferable to use for example, compounds represented by the general formula (I) nontoxic salts thereof or , hydrates of the same wherein each symbol has the meaning as defined in the description.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 9, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 9, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 9, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.